FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017002108> ?p ?o ?g. }

• W3017002108 endingPage "6" @default.
• W3017002108 startingPage "4" @default.
• W3017002108 abstract "HomeCirculationVol. 142, No. 1Obesity Is a Risk Factor for Severe COVID-19 Infection Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBObesity Is a Risk Factor for Severe COVID-19 InfectionMultiple Potential Mechanisms Naveed Sattar, Iain B. McInnes and John J.V. McMurray Naveed SattarNaveed Sattar Naveed Sattar, MD, Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom. Email E-mail Address: [email protected] https://orcid.org/0000-0002-1604-2593 Institute of Cardiovascular and Medical Sciences (N.S., J.J.V.M.), University of Glasgow, United Kingdom. Search for more papers by this author , Iain B. McInnesIain B. McInnes Institute of Infection, Immunity and Inflammation (I.B.M.), University of Glasgow, United Kingdom. Search for more papers by this author and John J.V. McMurrayJohn J.V. McMurray Institute of Cardiovascular and Medical Sciences (N.S., J.J.V.M.), University of Glasgow, United Kingdom. Search for more papers by this author Originally published22 Apr 2020https://doi.org/10.1161/CIRCULATIONAHA.120.047659Circulation. 2020;142:4–6Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: April 22, 2020: Ahead of Print The coronavirus disease 2019 (COVID-19) pandemic has led to worldwide research efforts to identify people at greatest risk of developing critical illness and dying. Initial data pointed toward older individuals being particularly vulnerable, as well as those with diabetes mellitus or cardiovascular (including hypertension), respiratory, or kidney disease. These problems are often concentrated in certain racial groups (eg, African Americans and Asians), which also appear to be more prone to worse COVID-19 outcomes.1 Increasing numbers of reports have linked obesity to more severe COVID-19 illness and death.1–3 In a French study, the risk for invasive mechanical ventilation in patients with COVID-19 infection admitted to the intensive treatment unit was more than 7-fold higher for those with body mass index (BMI) >35 compared with BMI <25 kg/m2.2 Among individuals with COVID-19 who were <60 years of age in New York City, those with a BMI between 30 to 34 kg/m2 and >35 kg/m2 were 1.8 times and 3.6 times more likely to be admitted to critical care, respectively, than individuals with a BMI <30 kg/m2.3We suggest obesity or excess ectopic fat deposition may be a unifying risk factor for severe COVID-19 infection, reducing protective cardiorespiratory reserve as well as potentiating the immune dysregulation that appears, at least in part, to mediate the progression to critical illness and organ failure in a proportion of patients with COVID-19 (Figure). Whether obesity is an independent risk factor for susceptibility to infection requires further research.Download figureDownload PowerPointFigure. Pathways potentially linking obesity or excess ectopic fat to more severe coronavirus disease 2019 (COVID-19) illness. There are multiple pathways by which obesity (or excess ectopic fat) may increase the effect of COVID-19 infection. These include underlying impairments in cardiovascular, respiratory, metabolic, and thrombotic pathways in relation to obesity, all of which reduce reserve and ability to cope with COVID-19 infection and the secondary immune reaction to it. At the same time, there are several reasons why obese individuals may have amplified or dysregulated immune response, linked both to greater viral exposure, as well as the possibility that excess adipose tissue potentiates the immune response. BP indicates blood pressure; COVID-19, coronavirus disease 2019; CV, cardiovascular; FEV1, forced expiratory volume; FVC, forced vital capacity; and SES, socioeconomic status.From a cardiovascular perspective, trial and genetic evidence conclusively show that obesity (and excess fat mass) are causally related to hypertension, diabetes mellitus, coronary heart disease, stroke, atrial fibrillation, renal disease, and heart failure. Obesity potentiates multiple cardiovascular risk factors, the premature development of cardiovascular disease, and adverse cardiorenal outcomes. There is also a metabolic concern. In individuals with diabetes mellitus, or at high risk of diabetes mellitus, obesity and excess ectopic fat lead to impairment of insulin resistance and reduced β-cell function. Both the latter limit ability to evoke an appropriate metabolic response on immunologic challenge, leading some patients with diabetes mellitus to require substantial amounts of insulin during severe infections. Overall, the integrated regulation of metabolism required for the complex cellular interactions, and for effective host defense, is lost, leading to functional immunologic deficit. COVID-19 may also directly disrupt pancreatic β-cell function through an interaction with angiotensin-converting enzyme 2. Furthermore, obesity enhances thrombosis, which is relevant given the association between severe COVID-19 and prothrombotic disseminated intravascular coagulation and high rates of venous thromboembolism.Beyond cardiometabolic and thrombotic consequences, obesity has detrimental effects on lung function, diminishing forced expiratory volume and forced vital capacity (Figure). Higher relative fat mass is also linked to such adverse changes, perhaps relevant to emerging reports of greater critical illness from COVID-19 in certain ethnicities, eg, Asians.1 Asians often display lower cardiorespiratory fitness and carry proportionally more fat tissue at lower BMIs. With extreme obesity (eg, BMI >40 kg/m2), care for individuals admitted to intensive therapy units is often impeded as these patients are more difficult to image, ventilate, nurse, and rehabilitate.With respect to the immune response, there is a clear association between obesity and basal inflammatory status characterized by higher circulating interleukin 6 and C-reactive protein levels. Adipose tissue in obesity is “proinflammatory,” with increased expression of cytokines and particularly adipokines. There is also dysregulated tissue leukocyte expression, and inflammatory macrophage (and innate lymphoid) subsets replace tissue regulatory (M2) phenotypic cells. Obesity per se is an independent and causal risk factor for the development of immune-mediated disease, eg, psoriasis,4 suggesting that such adipose state may have systemic immune consequence on additional environmental provocation. In terms of host defense, obesity impairs adaptive immune responses to influenza virus5 and conceivably could do so in COVID-19. Obese individuals may exhibit greater viral shedding, suggesting potential for great viral exposure, especially if several family members are overweight. This may be aggravated in overcrowded multigenerational households, which are more common in the socioeconomically deprived communities in which obesity is prevalent. All these observations point toward a potential for obesity to give rise to a more adverse virus versus host immune response relationship in COVID-19. Poorer nutritional status and hyperglycemia may further aggravate the situation in some obese individuals.Much of the focus of COVID-19 has been on older people. However, it is important to remember that weight and muscle mass start to decline at advanced age but relative fat mass increases, particularly in those with comorbid diseases such as cardiovascular and respiratory conditions. Older age is also associated with more hypertension and diabetes mellitus because of stiffer vessels and impaired metabolic efficiency, respectively. People who are older (eg, >70 years of age), similar to younger obese individuals, have less cardiorespiratory reserve to cope with COVID-19 infection. Immune senescence is well recognized, as is the concept of inflammaging, and both may influence virus–host dynamics in the elderly and infection outcomes.What are the implications of these emerging observations for future research and public health messaging? With respect to research, predictive instruments for those most at risk of severe outcomes should consider BMI. Mechanistic understanding of the relationship between obesity and COVID-19 may suggest therapeutic interventions (eg, proven weight loss drugs, low-calorie diets) to potentially reduce the risk of developing severe COVID-19 illness. With respect to public health, it is important to communicate risks without causing anxiety. People worldwide should be encouraged to improve their lifestyle to lessen risk both in the current and subsequent waves of COVID-19. In addition to increasing activity levels, there should be improved messaging on better diet, focusing on simpler advice to help people adopt sustainable changes. This is particularly challenging with current stay-at-home rules limiting activity levels—the lockdown cost of weight gain. Even more worrying is that the resultant economic downturn may worsen obesity, especially in the most vulnerable individuals, a risk that governments need to address after the current pandemic. Indeed, this pandemic has highlighted that more—not less—must be done to tackle and prevent obesity in societies for the prevention of chronic disease and greater adverse reactions to viral pandemics.AcknowledgmentsThe authors thank Liz Coyle from the University of Glasgow for her excellent technical assistance in the preparation of this article.Sources of FundingThe work in this study is supported by the British Heart Foundation Center of Research Excellence Grant RE/18/6/34217.DisclosuresDr Sattar reports personal fees from Amgen, AstraZeneca, Eli Lilly, Novo Nordisk, Pfizer, and Sanofi and personal fees and research grants from Boehringer Ingelheim outside the submitted work. Drs McInnes and McMurray report no conflicts.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.https://www.ahajournals.org/journal/circNaveed Sattar, MD, Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom. Email naveed.sattar@glasgow.ac.ukReferences1. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell LF, Chernyak Y, Tobin K, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.BMJ2020; 369:m1966. doi: 10.1136/bmj.m1966CrossrefMedlineGoogle Scholar2. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F, Jourdain M, Lille Intensive Care COVID-19 and Obesity Study Group. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation [published online April 9, 2020].Obesity (Silver Spring). doi: 10.1002/oby.22831. https://onlinelibrary.wiley.com/doi/10.1002/oby.22831Google Scholar3. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, Stachel A. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission [published online April 9, 2020].Clin Infect Dis. 2020. doi:10.1093/cid/ciaa415. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa415/5818333CrossrefGoogle Scholar4. Budu-Aggrey A, Brumpton B, Tyrrell J, Watkins S, Modalsli EH, Celis-Morales C, Ferguson LD, Vie GÅ, Palmer T, Fritsche LG, et al. Evidence of a causal relationship between body mass index and psoriasis: a mendelian randomization study.PLoS Med. 2019; 16:e1002739. doi: 10.1371/journal.pmed.1002739CrossrefMedlineGoogle Scholar5. Green WD, Beck MA. Obesity impairs the adaptive immune response to influenza virus.Ann Am Thorac Soc. 2017; 14(suppl 5):S406–S409. doi: 10.1513/AnnalsATS.201706-447AWCrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Henderson Y, Bithi N, Yang J, Link C, Zhang A, Baron B, Maina E and Hine C (2022) A long-term obesogenic high-fat diet in mice partially dampens the anti-frailty benefits of late-life intermittent fasting, GeroScience, 10.1007/s11357-022-00678-1, 45:2, (1247-1262), Online publication date: 1-Apr-2023. Li C, Baek J, Huang J and Jia B (2023) Bibliometric analysis reveals the Mediterranean diet can benefit against coronavirus disease 2019, New Microbes and New Infections, 10.1016/j.nmni.2023.101105, 52, (101105), Online publication date: 1-Mar-2023. Novák A, Szalánczi S, Hornyák B, Rázsó Z, Sótér A and Nyakas C (2023) CORRELATION BETWEEN COVID-19 SYMPTOMS AND CERTAIN PHYSIOLOGICAL AND BODY COMPOSITION PARAMETERS RELATED TO OBESITY AND OVERWEIGHT, Military Medical Science Letters, 10.31482/mmsl.2023.006 Tsao C, Aday A, Almarzooq Z, Anderson C, Arora P, Avery C, Baker-Smith C, Beaton A, Boehme A, Buxton A, Commodore-Mensah Y, Elkind M, Evenson K, Eze-Nliam C, Fugar S, Generoso G, Heard D, Hiremath S, Ho J, Kalani R, Kazi D, Ko D, Levine D, Liu J, Ma J, Magnani J, Michos E, Mussolino M, Navaneethan S, Parikh N, Poudel R, Rezk-Hanna M, Roth G, Shah N, St-Onge M, Thacker E, Virani S, Voeks J, Wang N, Wong N, Wong S, Yaffe K and Martin S (2023) Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association, Circulation, 147:8, (e93-e621), Online publication date: 21-Feb-2023. Chaudhuri R, Chatterjee S, Thrassou A and Vrontis D (2022) Antecedents of obesity among Indian youth: from consumer psychological and lifestyle perspective, British Food Journal, 10.1108/BFJ-10-2021-1151, 125:3, (1026-1053), Online publication date: 9-Feb-2023. Xiang M, Wu X, Jing H, Novakovic V and Shi J (2023) The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2023.1062491, 10 Mohamed A, Alrohaimi A, Sayed Abdelgeliel A, Albogami S, Jafri I, Fayad E, Mohamed N, Nassar N, Adaroas A, Eldeeb H, Abdel Halim A, Ramadan A, Elnagar R, Abdelghafour R, Mohamed A, Mahmoud M, El-Kasses A, El-Sayed M, Mohammed M, Alwaleed E, Mousa S, Abdel Salam S and Abd el salam S (2023) The Impact of LEP rs7799039 Polymorphism and Obesity on the Severity of Coronavirus Disease-19, Diabetes, Metabolic Syndrome and Obesity, 10.2147/DMSO.S391869, Volume 16, (515-522) Bogard G, Barthelemy J, Hantute-Ghesquier A, Sencio V, Brito-Rodrigues P, Séron K, Robil C, Flourens A, Pinet F, Eberlé D, Trottein F, Duterque-Coquillaud M and Wolowczuk I (2023) SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters, Cell Death & Disease, 10.1038/s41419-023-05574-w, 14:2 Azzolino D, Coelho-Junior H, Proietti M, Manzini V and Cesari M (2022) Fatigue in older persons: the role of nutrition, Proceedings of the Nutrition Society, 10.1017/S0029665122002683, 82:1, (39-46), Online publication date: 1-Feb-2023. Mauricio D, Vlacho B, Ortega E, Cos-Claramunt X, Mata-Cases M, Real J, Fernandez-Camins B and Franch-Nadal J (2023) Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves, Primary Care Diabetes, 10.1016/j.pcd.2022.12.002, 17:1, (12-18), Online publication date: 1-Feb-2023. Kamal S, Naghib M, Daadour M, Alsuliman M, Alanazi Z, Basalem A, Alaskar A and Saed K (2023) The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study, Viruses, 10.3390/v15020326, 15:2, (326) Santanatoglia A, Nzekoue F, Alesi A, Ricciutelli M, Sagratini G, Suo X, Torregiani E, Vittori S and Caprioli G (2023) Development of Innovative Vitamin D Enrichment Designs for Two Typical Italian Fresh Cheeses: Burrata and Giuncata, Molecules, 10.3390/molecules28031049, 28:3, (1049) Ito H, Sugimoto T, Ogihara Y, Kurita T, Tanabe M, Hirayama M, Isaji S, Dohi K and Mogi M (2023) Clinical characteristics and the risk of hospitalization of patients with coronavirus disease 2019 quarantined in a designated hotel in Japan, PLOS ONE, 10.1371/journal.pone.0280291, 18:1, (e0280291) Habis Y, Alsilmi R, Alirbidi L, Safhi M, Alsallum F, Alharbi R and Samman A Effect of Obesity on Clinical Outcomes in COVID-19 Patients, Cureus, 10.7759/cureus.33734 Kokaeva I, Zhernakova Y and Blinova N (2023) Endothelial dysfunction in patients with COVID-19 is a key mechanism for the development of complications, Systemic Hypertension, 10.38109/2075-082X-2022-4-37-44, 19:4, (37-44) Tong L, Khani M, Lu Q, Taylor B, Osinski K and Luo J (2023) Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study, Obesity Research & Clinical Practice, 10.1016/j.orcp.2022.12.003, 17:1, (47-57), Online publication date: 1-Jan-2023. Campbell J (2023) COVID-19: Reducing the risk via diet and lifestyle, Journal of Integrative Medicine, 10.1016/j.joim.2022.10.001, 21:1, (1-16), Online publication date: 1-Jan-2023. Ma W, Murray E, Nguyen L, Drew D, Ding M, Stopsack K, Rich-Edwards J, Hart J, Figueiredo J, Lacey J, Patel A, Bhupathiraju S, Chan A and Martinez M (2023) Physical Activity, Sedentary Behavior, and Risk of Coronavirus Disease 2019, The American Journal of Medicine, 10.1016/j.amjmed.2022.12.029, Online publication date: 1-Jan-2023. Faizo A, Qashqari F, El‐Kafrawy S, Barasheed O, Almashjary M, Alfelali M, Bawazir A, Albarakati B, Khayyat S, Hassan A, Alandijany T and Azhar E (2022) A potential association between obesity and reduced effectiveness of COVID‐19 vaccine‐induced neutralizing humoral immunity, Journal of Medical Virology, 10.1002/jmv.28130, 95:1, Online publication date: 1-Jan-2023. Abilbayeva A, Tarabayeva A, Idrisova G, Abdrakhmanova A, Sadykova A, Yegemberdiyeva R and Duisenova A Clinical and laboratory COVID-19 features in hospitalized patients with concomitant diabetes mellitus type 2: A retrospective study, Journal of Clinical Medicine of Kazakhstan, 10.23950/jcmk/12719, 19:6, (83-88) Karuniawati A, Syam A, Achmadsyah A, Ibrahim F, Rosa Y, Sudarmono P, Fadilah F and Rasmin M (2022) Case series in Indonesia: B.1.617.2 (delta) variant of SARS-CoV-2 infection after a second dose of vaccine, World Journal of Clinical Cases, 10.12998/wjcc.v10.i36.13216, 10:36, (13216-13226) Hafez W, Abdelshakor M, Kishk S, Gebril A, Gador M, Osman S, Abuelsaoud H and Abdelrahman A (2022) Body Mass Index and Clinical Outcomes in Adult COVID-19 Patients of Diverse Ethnicities, Healthcare, 10.3390/healthcare10122575, 10:12, (2575) Memar E, Mohsenipour R, Sadrosadat S and Rostami P (2022) Pediatric endocrinopathies related to COVID-19: an update, World Journal of Pediatrics, 10.1007/s12519-022-00662-x Soffer S, Zimlichman E, Glicksberg B, Efros O, Levin M, Freeman R, Reich D and Klang E (2022) Obesity as a mortality risk factor in the medical ward: a case control study, BMC Endocrine Disorders, 10.1186/s12902-021-00912-5, 22:1, Online publication date: 1-Dec-2022. Stojkoski V, Utkovski Z, Jolakoski P, Tevdovski D and Kocarev L (2022) Correlates of the country differences in the infection and mortality rates during the first wave of the COVID-19 pandemic: evidence from Bayesian model averaging, Scientific Reports, 10.1038/s41598-022-10894-6, 12:1, Online publication date: 1-Dec-2022. Jiang B, Yang Y, Chen L, Liu X, Wu X, Chen B, Webster C, Sullivan W, Larsen L, Wang J and Lu Y (2022) Green spaces, especially nearby forest, may reduce the SARS-CoV-2 infection rate: A nationwide study in the United States, Landscape and Urban Planning, 10.1016/j.landurbplan.2022.104583, 228, (104583), Online publication date: 1-Dec-2022. Bhattacharya J, Magness P and Kulldorff M (2022) Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes, Advances in Biological Regulation, 10.1016/j.jbior.2022.100916, 86, (100916), Online publication date: 1-Dec-2022. Tallon E, Ebekozien O, Sanchez J, Staggs V, Ferro D, McDonough R, Demeterco-Berggren C, Polsky S, Gomez P, Patel N, Prahalad P, Odugbesan O, Mathias P, Lee J, Smith C, Shyu C and Clements M (2022) Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection, Diabetes Research and Clinical Practice, 10.1016/j.diabres.2022.110156, 194, (110156), Online publication date: 1-Dec-2022. Zahid M, Leung V, Nayudu S, Galiveeti S, Mantri N, Sun H, Gongati S, Perugu V and Chilimuri S (2022) Role of body mass index in outcomes of patients hospitalized with COVID‐19 illness, Obesity Science & Practice, 10.1002/osp4.607, 8:6, (748-756), Online publication date: 1-Dec-2022. de Souza Bandeira Nunes A, Costa Souza K, Andrade do Nascimento A, Sousa Gabriel I, de Abreu Carolino R and Furtado Araújo da Silva M (2022) OBESIDADE E COVID - 19: QUAL SUA RELAÇÃO?, Revista interdisciplinar em saúde, 10.35621/23587490.v9.n1.p677-689, 9:Único, (677-689), Online publication date: 25-Nov-2022. Zekri-Nechar K, Barberán J, Zamorano-León J, Durbán M, Andrés-Castillo A, Navarro-Cuellar C, López-Farré A, López-de-Andrés A, Jiménez-García R and Martínez-Martínez C (2022) Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients, Medicina, 10.3390/medicina58111649, 58:11, (1649) Khokhlova Y, Markelova L and Titova N (2022) Comorbid diseases and conditions of patients with a novel coronavirus infection COVID-19, who died in infectious hospital, Perm Medical Journal, 10.17816/pmj39512-20, 39:5, (12-20) Abdullah N, Hashim N, Zainal Abidin I and Mohd Shazali S (2022) Impact of COVID-19 Pandemic in Malaysia: A Critical Survey, Pertanika Journal of Social Sciences and Humanities, 10.47836/pjssh.30.4.20, 30:4, (1857-1879) Azevedo R, Wandermurem D, Libório F, Machado M, Ushijima N, Narde R, D. Pecly I and Muxfeldt E Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review, Current Cardiology Reviews, 10.2174/1573403X18666220509154236, 18:6 Farrar D, Drouin O, Moore Hepburn C, Baerg K, Chan K, Cyr C, Donner E, Embree J, Farrell C, Forgie S, Giroux R, Kang K, King M, Laffin Thibodeau M, Orkin J, Ouldali N, Papenburg J, Pound C, Price V, Proulx-Gauthier J, Purewal R, Ricci C, Sadarangani M, Salvadori M, Thibeault R, Top K, Viel-Thériault I, Kakkar F and Morris S (2022) Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020–May 2021, The Lancet Regional Health - Americas, 10.1016/j.lana.2022.100337, 15, (100337), Online publication date: 1-Nov-2022. Chen G, Mainous A, Ayzengart A and Hong Y (2022) Association Between Bariatric Surgery and Severe COVID-19 Outcomes in Florida, Obesity Surgery, 10.1007/s11695-022-06281-9, 32:11, (3807-3810), Online publication date: 1-Nov-2022. Eskandari F, Lake A, Rose K, Butler M and O'Malley C (2022) A mixed‐method systematic review and meta‐analysis of the influences of food environments and food insecurity on obesity in high‐income countries, Food Science & Nutrition, 10.1002/fsn3.2969, 10:11, (3689-3723), Online publication date: 1-Nov-2022. Reis W, Moses O, Oh J, Wilson A, Gaio J and Dos Santos H (2022) The Association between Lifestyle Risk Factors and COVID-19 Hospitalization in a Healthcare Institution, American Journal of Lifestyle Medicine, 10.1177/15598276221135541, (155982762211355) Feremi K, Mousavinasab N and Gholipour Z (2022) Relationship between Insomnia and Blood Oxygen Levels in COVID-19 Patients Admitted to the Intensive Care Unit, Indian Journal of Sleep Medicine, 10.5005/jp-journals-10069-0103, 17:3, (72-76), Online publication date: 19-Oct-2022. Buchneva A, Chichkova N, Fominykh E, Krupochkina N and Fomin V (2022) COVID-19 and lung damage in obese patients: results of a prospective study, Meditsinskiy sovet = Medical Council, 10.21518/2079-701X-2022-16-18-162-169, 16:18, (162-169) Bucholc M, Bradley D, Bennett D, Patterson L, Spiers R, Gibson D, Van Woerden H and Bjourson A (2022) Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19, Scientific Reports, 10.1038/s41598-022-20176-w, 12:1 Ulaszewska K, Jodczyk A, Długołęcki P, Emerla S, Stańska W, Kasiak P, Gąsior J, Parol D, Mamcarz A and Śliż D (2022) Factors Associated with Willingness to Receive a COVID-19 Vaccine in Adult Polish Population—A Cross-Sectional Survey, Vaccines, 10.3390/vaccines10101715, 10:10, (1715) Niño Méndez O, Sierra Sampedro A, Ceballos Bernal E, Núñez Espinoza C and Rodríguez Mora J (2022) Impacto de la pandemia por COVID-19 en persona sana y físicamente activa. Reporte de un caso y actualización de los principales hallazgos, Revista de Investigación e Innovación en Ciencias de la Salud, 10.46634/riics.139, 4:2, (press), Online publication date: 4-Oct-2022. Beltrão F, Beltrão D, Carvalhal G, Beltrão F, de Aquino I, Brito T, Paulino B, Aires E, Viegas D, Hecht F, Halpern B, Pordeus L, Gonçalves M and Ramos H Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study, Endocrine Connections, 10.1530/EC-22-0290, 11:10 Collins W, Chang A, Weng Y, Dahlen A, O’Brien C, Hom J, Ahuja N, Rodriguez F and Rohatgi N (2022) Association between Obesity and Length of COVID-19 Hospitalization: Unexpected Insights from the American Heart Association National COVID-19 Registry, Journal of Obesity & Metabolic Syndrome, 10.7570/jomes22042, 31:3, (277-281), Online publication date: 30-Sep-2022. Park M and Chung N (2022) Changes in physical activity and energy intake according to abdominal obesity in Korean adult men before and after COVID-19: Data from 2019 and 2020 Korea National Health and Nutrition Examination Survey (KNHANES), Physical Activity and Nutrition, 10.20463/pan.2022.0013, 26:3, (006-015), Online publication date: 30-Sep-2022. Das P, Igoe M, Lenhart S, Luong L, Lanzas C, Lloyd A, Odoi A and Ximenez C (2022) Geographic disparities and determinants of COVID-19 incidence risk in the greater St. Louis Area, Missouri (United States), PLOS ONE, 10.1371/journal.pone.0274899, 17:9, (e0274899) Bencze D, Fekete T and Pázmándi K (2022) Correlation between Type I Interferon Associated Factors and COVID-19 Severity, International Journal of Molecular Sciences, 10.3390/ijms231810968, 23:18, (10968) Taraq Naem Zia U, Lee I and Mamat S (2022) Challenge of New Norms: Obesity amid COVID-19 Pandemic, Malaysian Journal of Medicine and Health Sciences, 10.47836/mjmhs.18.5.28, 18:5, (208-214) Lewis A, Abdesselam I, Rayner J, Byrne J, Borlaug B, Neubauer S and Rider O (2021) Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance, European Heart Journal - Cardiovascular Imaging, 10.1093/ehjci/jeab175, 23:10, (1383-1390), Online publication date: 10-Sep-2022. Paul E and Fancourt D (2022) Health behaviours the month prior to COVID-19 infection and the development of self-reported long COVID and specific long COVID symptoms: a longitudinal analysis of 1581 UK adults, BMC Public Health, 10.1186/s12889-022-14123-7, 22:1 Tolopka T, Kuehne J, Mainali K, Beebe M, Garcia M, Salameh M, Ocampo R and Bhalala U The Role of Childhood Obesity in Acute Presentations and Outcomes of Hospitalized COVID-19 Patients, Cureus, 10.7759/cureus.28911 Faridzadeh A, Mahmoudi M, Ghaffarpour S, Zamani M, Hoseinzadeh A, Naghizadeh M and Ghazanfari T (2022) The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study, Frontiers in Genetics, 10.3389/fgene.2022.955965, 13 Young D and Bates G (2022) Maximising the health impacts of free advice services in the UK: A mixed methods systematic review, Health & Social Care in the Community, 10.1111/hsc.13777, 30:5, (1713-1725), Online publication date: 1-Sep-2022. Schöning V and Hammann F (2022) Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients, Pharmaceutics, 10.3390/pharmaceutics14091828, 14:9, (1828) Khatib M (2022) The impact of Ramadan during COVID-19 confinement on weight, dietary, and lifestyle habits in the Kingdom of Saudi Arabia: a cross-sectional study, BMC Public Health, 10.1186/s12889-022-13953-9, 22:1 Srivastava A and Mussa B (2022) Effects of Varying Glucose Concentrations on ACE2′s Hypothalamic Expression and Its Potential Relation to COVID-19-Associated Neurological Dysfunction, International Journal of Molecular Sciences, 10.3390/ijms23179645, 23:17, (9645) Pomar C, Bonet M, Ferre-Beltrán A, Fraile-Ribot P, García-Gasalla M, Riera M, Picó C and Palou A (2022) Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution, Biomedicines, 10.3390/biomedicines1008" @default.
• W3017002108 created "2020-04-24" @default.
• W3017002108 creator A5006987054 @default.
• W3017002108 creator A5027213857 @default.
• W3017002108 creator A5071482630 @default.
• W3017002108 date "2020-07-07" @default.
• W3017002108 modified "2023-10-14" @default.
• W3017002108 title "Obesity Is a Risk Factor for Severe COVID-19 Infection" @default.
• W3017002108 cites W2770679757 @default.
• W3017002108 cites W2913651502 @default.
• W3017002108 cites W3015826289 @default.
• W3017002108 cites W3028583791 @default.
• W3017002108 doi "https://doi.org/10.1161/circulationaha.120.047659" @default.
• W3017002108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32320270" @default.
• W3017002108 hasPublicationYear "2020" @default.
• W3017002108 type Work @default.
• W3017002108 sameAs 3017002108 @default.
• W3017002108 citedByCount "553" @default.
• W3017002108 countsByYear W30170021082020 @default.
• W3017002108 countsByYear W30170021082021 @default.
• W3017002108 countsByYear W30170021082022 @default.
• W3017002108 countsByYear W30170021082023 @default.
• W3017002108 crossrefType "journal-article" @default.
• W3017002108 hasAuthorship W3017002108A5006987054 @default.
• W3017002108 hasAuthorship W3017002108A5027213857 @default.
• W3017002108 hasAuthorship W3017002108A5071482630 @default.
• W3017002108 hasBestOaLocation W30170021081 @default.
• W3017002108 hasConcept C116675565 @default.
• W3017002108 hasConcept C126322002 @default.
• W3017002108 hasConcept C159047783 @default.
• W3017002108 hasConcept C2778137277 @default.
• W3017002108 hasConcept C2779134260 @default.
• W3017002108 hasConcept C3006700255 @default.
• W3017002108 hasConcept C3007834351 @default.
• W3017002108 hasConcept C3008058167 @default.
• W3017002108 hasConcept C50440223 @default.
• W3017002108 hasConcept C511355011 @default.
• W3017002108 hasConcept C524204448 @default.
• W3017002108 hasConcept C71924100 @default.
• W3017002108 hasConceptScore W3017002108C116675565 @default.
• W3017002108 hasConceptScore W3017002108C126322002 @default.
• W3017002108 hasConceptScore W3017002108C159047783 @default.
• W3017002108 hasConceptScore W3017002108C2778137277 @default.
• W3017002108 hasConceptScore W3017002108C2779134260 @default.
• W3017002108 hasConceptScore W3017002108C3006700255 @default.
• W3017002108 hasConceptScore W3017002108C3007834351 @default.
• W3017002108 hasConceptScore W3017002108C3008058167 @default.
• W3017002108 hasConceptScore W3017002108C50440223 @default.
• W3017002108 hasConceptScore W3017002108C511355011 @default.
• W3017002108 hasConceptScore W3017002108C524204448 @default.
• W3017002108 hasConceptScore W3017002108C71924100 @default.
• W3017002108 hasIssue "1" @default.
• W3017002108 hasLocation W30170021081 @default.
• W3017002108 hasLocation W30170021082 @default.
• W3017002108 hasOpenAccess W3017002108 @default.
• W3017002108 hasPrimaryLocation W30170021081 @default.
• W3017002108 hasRelatedWork W3003901880 @default.
• W3017002108 hasRelatedWork W3005417802 @default.
• W3017002108 hasRelatedWork W3007868867 @default.
• W3017002108 hasRelatedWork W3009669391 @default.
• W3017002108 hasRelatedWork W3020699490 @default.
• W3017002108 hasRelatedWork W3036314732 @default.
• W3017002108 hasRelatedWork W3043486364 @default.
• W3017002108 hasRelatedWork W3084498529 @default.
• W3017002108 hasRelatedWork W4210401150 @default.
• W3017002108 hasRelatedWork W3127156785 @default.
• W3017002108 hasVolume "142" @default.
• W3017002108 isParatext "false" @default.
• W3017002108 isRetracted "false" @default.
• W3017002108 magId "3017002108" @default.
• W3017002108 workType "article" @default.